Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy

Abstract

Since neural progenitor cells can engraft stably into brain tumors and differentiate along the neuronal and glial line, we tested the hypothesis that transplanted cytosine deaminase (CD)-expressing ST14A cells (an immortalized neural progenitor cell line) can convert locally 5-fluorocytosine (5-FC) into 5-fluorouracil (5-FU) and produce a regression of glioma tumors. ST14A, retrovirally transduced with the E. coli CD gene, showed a strong bystander effect on glioma cells as assessed by in vitro assay. Intracerebral injection of C6 glioma cells generated a rapidly growing tumoral mass. DiI prelabeled ST14A, coinjected into the rat brain with C6 glioma cells, survived in the tumoral mass up to 10 days and their number was not affected by in vivo 5-FC treatment. In contrast, a significant decrease of the glioma tumoral mass (−50%) was observed in 5-FC-treated rats. 5-FC had no effect on the tumor in the absence of CD-expressing ST14A cells. Our results support the feasibility of systems based on intratumoral transplantation of prodrug-converting cells for brain tumor therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Aghi M, Hochberg F, Breakefield XO . Prodrug activation enzymes in cancer gene therapy. J Gene Med. 2000;2:148–164.

    Article  CAS  Google Scholar 

  2. Austin EA, Huber BE . A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol Pharmacol. 1993;43:380–387.

    CAS  PubMed  Google Scholar 

  3. Polak A, Scholer HJ . Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy. 1975;21:113–130.

    Article  CAS  Google Scholar 

  4. Mullen CA, Kilstrup M, Blaese RM . Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA. 1992;89:33–37.

    Article  CAS  Google Scholar 

  5. Freeman SM, Abboud CN, Whartenby KA, et al. The ‘bystander effect’: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 1993;53:5274–5283.

    CAS  Google Scholar 

  6. Huber BE, Austin EA, Richards CA, et al. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA. 1994;91:8302–8306.

    Article  CAS  Google Scholar 

  7. Benedetti S, Pirola B, Pollo B, et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med. 2000;6:447–450.

    Article  CAS  Google Scholar 

  8. Cattaneo E, Conti L . Generation and characterization of embryonic striatal conditionally immortalized ST14A cells. J Neurosci Res. 1998;53:223–234.

    Article  CAS  Google Scholar 

  9. Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.

    Article  CAS  Google Scholar 

  10. Paxinos G, Watson C . The Rat Brain in Stereotaxic Coordinates, 2nd edn. Australia: Academic Press; 1986.

    Google Scholar 

  11. Mullen CA . Metabolic suicide genes in gene therapy. Pharmacol Ther. 1994;63:199–207.

    Article  CAS  Google Scholar 

  12. Haberkorn U, Oberdorfer F, Gebert J, et al. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine. J Nucl Med. 1996;37:87–94.

    CAS  PubMed  Google Scholar 

  13. Vermes A, Guchelaar H-J, Dankert J . Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother. 2000;46:171–179.

    Article  CAS  Google Scholar 

  14. Huang RP, Hossain MZ, Sehgal A, et al. Reduced connexin43 expression in high-grade human brain glioma cells. J Surg Oncol. 1999;70:21–24.

    Article  CAS  Google Scholar 

  15. McDonough WS, Johansson A, Joffee H, et al. Gap junction intercellular communication in gliomas is inversely related to cell motility. Int J Dev Neurosci. 1999;17:601–611.

    Article  CAS  Google Scholar 

  16. Shinoura N, Chen L, Wani MA, et al. Protein and messenger RNA expression of connexin 43 in astrocytomas: implications in brain tumor gene therapy. J Neurosurg. 1996;84:839–846.

    Article  CAS  Google Scholar 

  17. Soroceanu L, Manning JT, Sontheimer H . Expression of connexin-43 and functional gap junction coupling in human gliomas. Glia. 2001;33:107–117.

    Article  CAS  Google Scholar 

  18. Zhu D, Caveney S, Kidder GM, et al. Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc Natl Acad Sci USA. 1991;88:1883–1887.

    Article  CAS  Google Scholar 

  19. Lundberg C, Martinez-Serrano A, Cattaneo E, et al. Survival, integration, and differentiation of neural stem cell lines after transplantation to the adult rat striatum. Exp Neurol. 1997;145:342–360.

    Article  CAS  Google Scholar 

  20. Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA. 2000;97:12846–12851.

    Article  CAS  Google Scholar 

  21. Snyder EY, Taylor RM, Wolfe JH . Neural peogenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature. 1995;374:367–370.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Prof. AM Giuffrida Stella for her continuous support and encouragement during all the stages of this work. Barresi V was supported by a postdoctoral fellowship (borsa post-dottorato ed assegno di ricerca) of the University of Catania (Italy) and a travel grant by the Italian Interuniversity Consortium for Biotechnologies (CIB). Portions of this work were presented at the Joint 18th Biennal Meeting of the International Society for Neurochemistry (ISN) and the 32nd Annual Meeting of the American Society for Neurochemistry (ASN) 26–31 August 2001, Buenos Aires (Argentina).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniele Filippo Condorelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barresi, V., Belluardo, N., Sipione, S. et al. Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy. Cancer Gene Ther 10, 396–402 (2003). https://doi.org/10.1038/sj.cgt.7700580

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700580

Keywords

This article is cited by

Search

Quick links